Suppr超能文献

在有和没有现场心脏手术的中心评估左主干冠状动脉疾病患者的急性冠状动脉综合征。来自波兰急性冠状动脉综合征(PL-ACS)注册研究的数据。

Assessment of acute coronary syndromes among patients with left main coronary artery disease in centers with and without cardiac surgery on-site. Data from PL-ACS registry.

作者信息

Śmiech Karol, Brust Krzysztof, Bujak Kamil, Gąsior Mariusz, Roleder Tomasz

机构信息

Regional Specialist Hospital, Research and Development Center, Wroclaw, Poland.

3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze Medical University of Silesia in Katowice, Poland.

出版信息

Cardiol J. 2025;32(3):278-290. doi: 10.5603/cj.98087. Epub 2025 May 21.

Abstract

BACKGROUND

The treatment of left main coronary artery disease (LMCAD) in acute coronary syndrome patients is challenging in daily clinical practice. Therefore, the question arises whether the clinical outcomes of acute coronary syndrome (ACS) patients with LM disease vary between centers with and without cardiac surgery on site.

METHODS

The study is a retrospective analysis of ACS patient outcomes using data from the PL-ACS registry, which is a Polish archive of ACS patients. The following analysis considered patients with LMCAD (n=4000) who were divided into two groups: those treated in the centers with the cardiac surgery department on site (CS group, n=427) and those without (non-CS group, n=3573).

RESULTS

Patients with ACS in non-CS group more often were not qualified for revascularization than patients in CS group (11.7% in the CS group vs. 19.9% in the non-CS group, p<0.001), however, CABG was more common in non-CS group (18.7% in CS group vs. 25.7% in non-CS group, p<0.001). PCI, including angioplasty of LM, was more common in CS-group than non-CS group (38,6% vs. 30,3%, p<0.001). Among patients with ACS in CS group, major adverse cardiac events (MACE) were observed with greater frequency.

CONCLUSIONS

Patients with LM disease admitted to the centers with CS initially had more risk factors for more intensive hospitalization compared to patients in centers without CS on-site. Clinical outcomes and treatment procedures may differ regarding the availability of CS on-site.

摘要

背景

在日常临床实践中,急性冠状动脉综合征患者左主干冠状动脉疾病(LMCAD)的治疗具有挑战性。因此,问题在于有心脏外科手术和没有心脏外科手术的中心,急性冠状动脉综合征(ACS)合并左主干病变患者的临床结局是否存在差异。

方法

本研究是一项对ACS患者结局的回顾性分析,使用来自波兰ACS患者数据库PL-ACS登记处的数据。以下分析纳入了4000例LMCAD患者,分为两组:在有心脏外科的中心接受治疗的患者(CS组,n = 427)和没有心脏外科的中心的患者(非CS组,n = 3573)。

结果

非CS组的ACS患者比CS组的患者更常不符合血运重建条件(CS组为11.7%,非CS组为19.9%,p<0.001),然而,冠状动脉旁路移植术(CABG)在非CS组更常见(CS组为18.7%,非CS组为25.7%,p<0.001)。包括左主干血管成形术在内的经皮冠状动脉介入治疗(PCI)在CS组比非CS组更常见(38.6%对30.3%,p<0.001)。在CS组的ACS患者中,主要不良心脏事件(MACE)的发生率更高。

结论

与没有心脏外科的中心的患者相比,入住有心脏外科的中心的左主干病变患者最初有更多危险因素,需要更强化的住院治疗。临床结局和治疗程序可能因是否有心脏外科而有所不同。

相似文献

2
Indobufen versus aspirin after percutaneous coronary intervention in elderly patients with acute coronary syndrome.
BMC Cardiovasc Disord. 2025 Jul 7;25(1):495. doi: 10.1186/s12872-025-04843-0.
6
7
Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes.
EuroIntervention. 2024 Aug 19;20(16):996-1007. doi: 10.4244/EIJ-D-23-01049.
8
FFR-Guided Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Diabetes.
JAMA Cardiol. 2025 Jun 1;10(6):603-608. doi: 10.1001/jamacardio.2025.0095.
9
Coronary artery stents: a rapid systematic review and economic evaluation.
Health Technol Assess. 2004 Sep;8(35):iii-iv, 1-242. doi: 10.3310/hta8350.

本文引用的文献

1
Contemporary Left Main Percutaneous Coronary Intervention: A State-of-the-art Review.
Interv Cardiol. 2023 May 26;18:e20. doi: 10.15420/icr.2023.02. eCollection 2023.
2
PCI or CABG for left main coronary artery disease: the SWEDEHEART registry.
Eur Heart J. 2023 Aug 7;44(30):2833-2842. doi: 10.1093/eurheartj/ehad369.
3
Variations in Coronary Revascularization Practices and Their Effect on Long-Term Outcomes.
J Am Heart Assoc. 2022 Mar;11(5):e022770. doi: 10.1161/JAHA.121.022770. Epub 2022 Feb 28.
4
Revascularization in Patients With Left Main Coronary Artery Disease and Left Ventricular Dysfunction.
J Am Coll Cardiol. 2020 Sep 22;76(12):1395-1406. doi: 10.1016/j.jacc.2020.07.047.
6
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.
N Engl J Med. 2019 Nov 7;381(19):1820-1830. doi: 10.1056/NEJMoa1909406. Epub 2019 Sep 28.
7
'Ten commandments' for the 2018 ESC/EACTS Guidelines on Myocardial Revascularization.
Eur Heart J. 2019 Jan 7;40(2):79-80. doi: 10.1093/eurheartj/ehy855.
8
Comments on the 2018 ESC/EACTS Guidelines for Myocardial Revascularization.
Rev Esp Cardiol (Engl Ed). 2019 Jan;72(1):16-20. doi: 10.1016/j.rec.2018.11.010.
9
10-Year Outcomes of Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease.
J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2813-2822. doi: 10.1016/j.jacc.2018.09.012. Epub 2018 Sep 24.
10
2018 ESC/EACTS Guidelines on myocardial revascularization.
Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验